The invention relates to novel pyridocarbazole derivatives having highly selective action in inhibiting cyclic GMP-phosphodiesterase (hereinafter abbreviated as cGMP-PDE), processes for producing such derivatives, agents containing at least one of such derivatives as an active ingredient for preventing and/or treating pulmonary hypertension, ischemic heart diseases or diseases against which the cGMP-PDE inhibitory action is effective, and intermediates useful for the production of pyridocarbazole derivatives.
本发明涉及一种新型
吡啶咔唑衍
生物,具有高度选择性的抑制环
磷酸鸟苷酸磷酸二酯酶(以下简称为cGMP-PDE)的作用,以及制备这种衍
生物的方法,包含至少一种这样的衍
生物作为活性成分的制剂,用于预防和/或治疗肺动脉高压、缺血性心脏病或针对cGMP-PDE抑制作用有效的疾病,以及用于生产
吡啶咔唑衍
生物的中间体。